Kidney disease, race, and gfr estimation

Clinical Journal of the American Society of Nephrology

Volumn 15, Issue 8, 2020, Pages 1203-1212

  Levey, Andrew S ^a   Titan, Silvia M ^a   Powe, Neil R ^b   Coresh, Josef ^c   Inker, Lesley A ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CIMETIDINE; CREATININE; CYSTATIN C; DOLUTEGRAVIR; FENOFIBRATE; RITONAVIR; TRIMETHOPRIM; BIOLOGICAL MARKER; CST3 PROTEIN, HUMAN;

ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BODY COMPOSITION; CENTRAL NERVOUS SYSTEM; CREATININE CLEARANCE; DECISION MAKING; ESTIMATED GLOMERULAR FILTRATION RATE; GLOMERULUS FILTRATION RATE; HEALTH CARE PERSONNEL; HUMAN; KIDNEY DISEASE; KIDNEY POLYCYSTIC DISEASE; MUSCLE MASS; OUTCOME ASSESSMENT; PUBLIC HEALTH; SOCIOECONOMICS; VALIDATION PROCESS; BIOLOGICAL MODEL; BLOOD; ETHNOLOGY; HEALTH DISPARITY; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; REPRODUCIBILITY;

BIOMARKERS; CREATININE; CYSTATIN C; GLOMERULAR FILTRATION RATE; HEALTH STATUS DISPARITIES; HUMANS; KIDNEY; KIDNEY DISEASES; MODELS, BIOLOGICAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RACE FACTORS; REPRODUCIBILITY OF RESULTS;

EID: 85088472321     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.12791019     Document Type: Article

References (75)

1. Levey AS, Coresh J, Tighiouart H, Greene T, Inker LA: Strengths and limitations of estimated and measured GFR. Nat Rev Nephrol 15: 784, 2019
2. Susantitaphong P, Cruz DN, Cerda J, Abulfaraj M, Alqahtani F, Koulouridis I, Jaber BL; Acute Kidney Injury Advisory Group of the American Society of Nephrology: World incidence of AKI: A meta-analysis. Clin J Am Soc Nephrol 8: 1482–1493, 2013
3. GBD 2017 Disease and Injury Incidence and Prevalence Col-laborators: Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 392: 1789–1858, 2018
4. GBD 2017 Causes of Death Collaborators: Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet 392: 1736–1788, 2018
5. Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW: Chronic kidney disease: Global dimension and perspectives. Lancet 382: 260–272, 2013
6. Thomas B, Matsushita K, Abate KH, Al-Aly Z, Ärnlöv J, Asayama K, Atkins R, Badawi A, Ballew SH, Banerjee A, Barregård L, Barrett-Connor E, Basu S, Bello AK, Bensenor I, Bergstrom J, Bikbov B, Blosser C, Brenner H, Carrero JJ, Chadban S, Cirillo M, Cortinovis M, Courville K, Dandona L, Dandona R, Estep K, Fernandes J, Fischer F, Fox C, Gansevoort RT, Gona PN, Gutierrez OM, Hamidi S, Hanson SW, Himmelfarb J, Jassal SK, Jee SH, Jha V, Jimenez-Corona A, Jonas JB, Kengne AP, Khader Y, Khang YH, Kim YJ, Klein B, Klein R, Kokubo Y, Kolte D, Lee K, Levey AS, Li Y, Lotufo P, El Razek HMA, Mendoza W, Metoki H, Mok Y, Muraki I, Muntner PM, Noda H, Ohkubo T, Ortiz A, Perico N, Polkinghorne K, Al-Radaddi R, Remuzzi G, Roth G, Rothenbacher D, Satoh M, Saum KU, Sawhney M, Schöttker B, Shankar A, Shlipak M, Silva DAS, Toyoshima H, Ukwaja K, Umesawa M, Vollset SE, Warnock DG, Werdecker A, Yamagishi K, Yano Y, Yonemoto N, Zaki MES, Naghavi M, Forouzanfar MH, Murray CJL, Coresh J, Vos T; Global Burden of Disease 2013 GFR Collaborators; CKD Prognosis Consortium; Global Burden of Disease Genitourinary Expert Group: Global Cardiovascular and renal outcomes of reduced GFR. J Am Soc Nephrol 28: 2167–2179, 2017
7. Saran R, Robinson B, Abbott KC, Agodoa LY, Albertus P, Ayanian J, Balkrishnan R, Bragg-Gresham J, Cao J, Chen JL, Cope E, Dharmarajan S, Dietrich X, Eckard A, Eggers PW, Gaber C, Gillen D, Gipson D, Gu H, Hailpern SM, Hall YN, Han Y, He K, Hebert H, Helmuth M, Herman W, Heung M, Hutton D, Jacobsen SJ, Ji N, Jin Y, Kalantar-Zadeh K, Kapke A, Katz R, Kovesdy CP, Kurtz V, Lavalee D, Li Y, Lu Y, McCullough K, Molnar MZ, Montez-Rath M, Morgenstern H, Mu Q, Mukhopadhyay P, Nallamothu B, Nguyen DV, Norris KC, O’Hare AM, Obi Y, Pearson J, Pisoni R, Plattner B, Port FK, Potukuchi P, Rao P, Ratkowiak K, Ravel V, Ray D, Rhee CM, Schaubel DE, Selewski DT, Shaw S, Shi J, Shieu M, Sim JJ, Song P, Soohoo M, Steffick D, Streja E, Tamura MK, Tentori F, Tilea A, Tong L, Turf M, Wang D, Wang M, Woodside K, Wyncott A, Xin X, Zang W, Zepel L, Zhang S, Zho H, Hirth RA, Shahinian V: United States Renal Data System. 2016 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2016
8. Powe NR: To have and have not: Health and health care disparities in chronic kidney disease. Kidney Int 64: 763–772, 2003
9. Powe NR: CKD progression: Teasing out contributions of elements in the human exposome. Am J Kidney Dis 73: 581–582, 2019
10. Pollak MR, Genovese G, Friedman DJ: APOL1 and kidney disease. Curr Opin Nephrol Hypertens 21: 179–182, 2012
11. Institute of Medicine: Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care, Washington, DC, The National Academies Press, 2003
12. Office of Management and Budget: Revisions to the standards for the classification of federal data on race and ethnicity, 1997. Available at: https://obamawhitehouse.archives.gov/omb/fedreg_1997standards. Accessed March 3, 2019
13. Anonymous: Genes, drugs and race. Nat Genet 29: 239–240, 2001
14. American Anthropology Association: AAA statement on race. Available at: https://www.americananthro.org/ConnectWithAAA/Content.aspx?ItemNumber=2583. Accessed March 3, 2019
15. Burchard EG, Ziv E, Coyle N, Gomez SL, Tang H, Karter AJ, Mountain JL, Pérez-Stable EJ, Sheppard D, Risch N: The impor-tance of race and ethnic background in biomedical research and clinical practice. N Engl J Med 348: 1170–1175, 2003
16. Sankar P, Cho MK: Genetics. Toward a new vocabulary of human genetic variation. Science 298: 1337–1338, 2002
17. Race, Ethnicity, and Genetics Working Group: The use of racial, ethnic, and ancestral categories in human genetics research. Am J Hum Genet 77: 519–532, 2005
18. Gravlee CC: How race becomes biology: Embodiment of social inequality. Am J Phys Anthropol 139: 47–57, 2009
19. Foster MW: Looking for race in all the wrong places: Analyzing the lack of productivity in the ongoing debate about race and ge-netics. Hum Genet 126: 355–362, 2009
20. Witzig R: The medicalization of race: Scientific legitimization of a flawed social construct. Ann Intern Med 125: 675–679, 1996
21. Lorusso L: The justification of race in biological explanation. J Med Ethics 37: 535–539, 2011
22. Shriver MD, Kittles RA: Genetic ancestry and the search for per-sonalized genetic histories. Nat Rev Genet 5: 611–618, 2004
23. Wright JT Jr., Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, Rostand SG; African American Study of Kidney Disease and Hypertension Study Group: Effect of blood pressure lowering and antihyper-tensive drug class on progression of hypertensive kidney disease: Results from the AASK trial. JAMA 288: 2421–2431, 2002
24. Soveri I, Berg UB, Björk J, Elinder CG, Grubb A, Mejare I, Sterner G, Bäck SE; SBU GFR Review Group: Measuring GFR: A systematic review. Am J Kidney Dis 64: 411–424, 2014
25. Kidney Disease: Improving global outcomes (KDIGO) CKD Work Group: KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3: 1–150, 2013
26. Kidney disease: Improving global outcomes (KDIGO) acute kidney injury work group: KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2: 1–138, 2012
27. Eneanya ND, Yang W, Reese PP: Reconsidering the consequences of using race to estimate kidney function. JAMA 322: 113–114, 2019
28. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604–612, 2009
29. Pottel H, Hoste L, Dubourg L, Ebert N, Schaeffner E, Eriksen BO, Melsom T, Lamb EJ, Rule AD, Turner ST, Glassock RJ, De Souza V, Selistre L, Mariat C, Martens F, Delanaye P: An estimated glomerular filtration rate equation for the full age spectrum. Nephrol Dial Transplant 31: 798–806, 2016
30. Pottel H, Delanaye P, Schaeffner E, Dubourg L, Eriksen BO, Melsom T, Lamb EJ, Rule AD, Turner ST, Glassock RJ, De Souza V, Selistre L, Goffin K, Pauwels S, Mariat C, Flamant M, Ebert N: Estimating glomerular filtration rate for the full age spectrum from serum creatinine and cystatin C. Nephrol Dial Transplant 32: 497–507, 2017
31. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461–470, 1999
32. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F; Chronic Kidney Disease Epidemiology Collaboration: Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145: 247–254, 2006
33. Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J, Rossert J, Van Lente F, Bruce RD 3rd, Zhang YL, Greene T, Levey AS: Estimating GFR using serum cystatin C alone and in combi-nation with serum creatinine: A pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis 51: 395–406, 2008
34. Inker LA, Eckfeldt J, Levey AS, Leiendecker-Foster C, Rynders G, Manzi J, Waheed S, Coresh J: Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values. Am J Kidney Dis 58: 682–684, 2011
35. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS; CKD-EPI Investigators: Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367: 20–29, 2012
36. Inker LA, Tighiouart H, Coresh J, Foster MC, Anderson AH, Beck GJ, Contreras G, Greene T, Karger AB, Kusek JW, Lash J, Lewis J, Schelling JR, Navaneethan SD, Sondheimer J, Shafi T, Levey AS: GFR estimation using b-trace protein and b2-microglobulin in CKD. Am J Kidney Dis 67: 40–48, 2016
37. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Van Lente F; Chronic Kidney Disease Epidemiology Collaboration: Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 53: 766–772, 2007
38. Poggio ED, Wang X, Greene T, Van Lente F, Hall PM: Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol 16: 459–466, 2005
39. Delanaye P, Mariat C, Maillard N, KrzesinskiJ-M, Cavalier E: Are the creatinine-based equations accurate to estimate glomerular filtration rate in African American populations? Clin J Am Soc Nephrol 6: 906–912, 2011
40. Flamant M, Vidal-Petiot E, Metzger M, Haymann JP, Letavernier E, Delatour V, Karras A, Thervet E, Boffa JJ, Houillier P, Stengel B, Vrtovsnik F, Froissart M; NephroTest Study Group: Performance of GFR estimating equations in African Europeans: Basis for a lower race-ethnicity factor than in African Americans. Am J Kidney Dis 62: 182–184, 2013
41. van Deventer HE, George JA, Paiker JE, Becker PJ, Katz IJ: Estimating glomerular filtration rate in black South Africans by use of the modification of diet in renal disease and Cockcroft-Gault equations. Clin Chem 54: 1197–1202, 2008
42. Yayo E, Ayé M, Yao C, Gnionsahé A, Attoungbré ML, Cavalier E, Pottel H, Monnet D, Delanaye P: Measured (and estimated) glomerular filtration rate: Reference values in West Africa. Nephrol Dial Transplant 33: 1176–1180, 2018
43. Moodley N, Hariparshad S, Peer F, Gounden V: Evaluation of the CKD-EPI creatinine based glomerular filtration rate estimating equation in Black African and Indian adults in KwaZulu-Natal, South Africa. Clin Biochem 59: 43–49, 2018
44. Bukabau JB, Yayo E, Gnionsahé A, Monnet D, Pottel H, Cavalier E, Nkodila A, Makulo JRR, Mokoli VM, Lepira FB, Nseka NM, KrzesinskiJ-M, Sumaili EK, Delanaye P: Performance of creati-nine-or cystatin C-based equations to estimate glomerular filtration rate in sub-Saharan African populations. Kidney Int 95: 1181–1189, 2019
45. Stevens LA, Claybon MA, Schmid CH, Chen J, Horio M, Imai E, Nelson RG, Van Deventer M, Wang HY, Zuo L, Zhang YL, Levey AS: Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int 79: 555–562, 2011
46. Teo BW, Zhang L, GuhJ-Y, Tang SCW, Jha V, KangD-H, Tanchanco R, Hooi LS, Praditpornsilpa K, Kong X, Zuo L, Chan GC, Lee EJC: Glomerular filtration rates in Asians. Adv Chronic Kidney Dis 25: 41–48, 2018
47. Rule AD, Teo BW: GFR estimation in Japan and China: What accounts for the difference? Am J Kidney Dis 53: 932–935, 2009
48. Waikar SS, Rebholz CM, Zheng Z, Hurwitz S, Hsu CY, Feldman HI, Xie D, Liu KD, Mifflin TE, Eckfeldt JH, Kimmel PL, Vasan RS, Bonventre JV, Inker LA, Coresh J; Chronic Kidney Disease Bio-markers Consortium Investigators: Biological variability of estimated GFR and albuminuria in CKD. Am J Kidney Dis 72: 538–546, 2018
49. Gallagher D, Visser M, De Meersman RE, Sepúlveda D, Baumgartner RN, Pierson RN, Harris T, Heymsfield SB: Appen-dicular skeletal muscle mass: Effects of age, gender, and ethnicity. J Appl Physiol (1985) 83: 229–239, 1997
50. Barondess DA, Nelson DA, Schlaen SE: Whole body bone, fat, and lean mass in black and white men. J Bone Miner Res 12: 967–971, 1997
51. Goldwasser P, Aboul-Magd A, Maru M: Race and creatinine excretion in chronic renal insufficiency. Am J Kidney Dis 30: 16–22, 1997
52. James GD, Sealey JE, Alderman M, Ljungman S, Mueller FB, Pecker MS, Laragh JH: A longitudinal study of urinary creatinine and creatinine clearance in normal subjects. Race, sex, and age differences. Am J Hypertens 1: 124–131, 1988
53. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL: Urinary creatinine concentrations in the U.S. population: Implications for urinary biologic monitoring measurements. En-viron Health Perspect 113: 192–200, 2005
54. Cohn SH, Abesamis C, Zanzi I, Aloia JF, Yasumura S, Ellis KJ: Body elemental composition: Comparison between black and white adults. Am J Physiol 232: E419–E422, 1977
55. Harsha DW, Frerichs RR, Berenson GS: Densitometry and an-thropometry of black and white children. Hum Biol 50: 261–280, 1978
56. Worrall JG, Phongsathorn V, Hooper RJ, Paice EW: Racial variation in serum creatine kinase unrelated to lean body mass. Br J Rheumatol 29: 371–373, 1990
57. Aloia JF, Vaswani A, Feuerman M, Mikhail M, Ma R: Differences in skeletal and muscle mass with aging in black and white women. Am J Physiol Endocrinol Metab 278: E1153–E1157, 2000
58. Ix JH, Wassel CL, Stevens LA, Beck GJ, Froissart M, Navis G, Rodby R, Torres VE, Zhang YL, Greene T, Levey AS: Equations to estimate creatinine excretion rate: The CKD epidemiology collaboration. Clin J Am Soc Nephrol 6: 184–191, 2011
59. Banda Y, Kvale MN, Hoffmann TJ, Hesselson SE, Ranatunga D, Tang H, Sabatti C, Croen LA, Dispensa BP, Henderson M, Iribarren C, Jorgenson E, Kushi LH, Ludwig D, Olberg D, Quesenberry CP Jr., Rowell S, Sadler M, Sakoda LC, Sciortino S, Shen L, Smethurst D, Somkin CP, Van Den Eeden SK, Walter L, Whitmer RA, Kwok PY, Schaefer C, Risch N: Characterizing race/ethnicityand genetic ancestry for 100,000 subjects in the genetic epidemiology research on adult health and aging (GERA) Cohort. Genetics 200: 1285–1295, 2015
60. Udler MS, Nadkarni GN, Belbin G, Lotay V, Wyatt C, Gottesman O, Bottinger EP, Kenny EE, Peter I: Effect of genetic african ancestry on eGFR and kidney disease. J Am Soc Nephrol 26: 1682–1692, 2015
61. Coresh J, Toto RD, Kirk KA, Whelton PK, Massry S, Jones C, Agodoa L, Van Lente F: Creatinine clearance as a measure of GFR in screenees for the african-American study of kidney disease and hypertension pilot study. Am J Kidney Dis 32: 32–42, 1998
62. Wuttke M, Li Y, Li M, Sieber KB, Feitosa MF, Gorski M, Tin A, Wang L, Chu AY, Hoppmann A, Kirsten H, Giri A, Chai JF, Sveinbjornsson G, Tayo BO, Nutile T, Fuchsberger C, Marten J, Cocca M, Ghasemi S, Xu Y, Horn K, Noce D, van der Most PJ, Sedaghat S, Yu Z, Akiyama M, Afaq S, Ahluwalia TS, Almgren P, Amin N, Ärnlöv J, Bakker SJL, Bansal N, Baptista D, Bergmann S, Biggs ML, Biino G, Boehnke M, Boerwinkle E, Boissel M, Bottinger EP, Boutin TS, Brenner H, Brumat M, Burkhardt R, Butterworth AS, Campana E, Campbell A, Campbell H, Canouil M, Carroll RJ, Catamo E, Chambers JC, Chee ML, Chee ML, Chen X, Cheng CY, Cheng Y, Christensen K, Cifkova R, Ciullo M, Concas MP, Cook JP, Coresh J, Corre T, Sala CF, Cusi D, Danesh J, Daw EW, de Borst MH, De Grandi A, de Mutsert R, de Vries APJ, Degenhardt F, Delgado G, Demirkan A, Di Angelantonio E, Dittrich K, Divers J, Dorajoo R, Eckardt KU, Ehret G, Elliott P, Endlich K, Evans MK, Felix JF, Foo VHX, Franco OH, Franke A, Freedman BI, Freitag-Wolf S, Friedlander Y, Froguel P, Gansevoort RT, Gao H, Gasparini P, Gaziano JM, Giedraitis V, Gieger C, Girotto G, Giulianini F, Gögele M, Gordon SD, Gudbjartsson DF, Gudnason V, Haller T, Hamet P, Harris TB, Hartman CA, Hayward C, Hellwege JN, Heng CK, Hicks AA, Hofer E, Huang W, Hutri-Kähönen N, Hwang SJ, Ikram MA, Indridason OS, Ingelsson E, Ising M, Jaddoe VWV, Jakobsdottir J, Jonas JB, Joshi PK, Josyula NS, Jung B, Kähönen M, Kamatani Y, Kammerer CM, Kanai M, Kastarinen M, Kerr SM, Khor CC, Kiess W, Kleber ME, Koenig W, Kooner JS, Körner A, Kovacs P, Kraja AT, Krajcoviechova A, Kramer H, Krämer BK, Kronenberg F, Kubo M, Kühnel B, Kuokkanen M, Kuusisto J, La Bianca M, Laakso M, Lange LA, Langefeld CD, Lee JJ, Lehne B, Lehtimäki T, Lieb W, Lim SC, Lind L, Lindgren CM, Liu J, Liu J, Loeffler M, Loos RJF, Lucae S, Lukas MA, Lyytikäinen LP, Mägi R, Magnusson PKE, Mahajan A, Martin NG, Martins J, März W, Mascalzoni D, Matsuda K, Meisinger C, Meitinger T, Melander O, Metspalu A, Mikaelsdottir EK, Milaneschi Y, Miliku K, Mishra PP, Mohlke KL, Mononen N, Montgomery GW, Mook-Kanamori DO, Mychaleckyj JC, Nadkarni GN, Nalls MA, Nauck M, Nikus K, Ning B, Nolte IM, Noordam R, O’Connell J, O’Donoghue ML, Olafsson I, Oldehinkel AJ, Orho-Melander M, Ouwehand WH, Padmanabhan S, Palmer ND, Palsson R, Penninx BWJH, Perls T, Perola M, Pirastu M, Pirastu N, Pistis G, Podgornaia AI, Polasek O, Ponte B, Porteous DJ, Poulain T, Pramstaller PP, Preuss MH, Prins BP, Province MA, Rabelink TJ, Raffield LM, Raitakari OT, Reilly DF, Rettig R, Rheinberger M, Rice KM, Ridker PM, Rivadeneira F, Rizzi F, Roberts DJ, Robino A, Rossing P, Rudan I, Rueedi R, Ruggiero D, Ryan KA, Saba Y, Sabanayagam C, Salomaa V, Salvi E, Saum KU, Schmidt H, Schmidt R, Schöttker B, Schulz CA, Schupf N, Shaffer CM, Shi Y, Smith AV, Smith BH, Soranzo N, Spracklen CN, Strauch K, Stringham HM, Stumvoll M, Svensson PO, Szymczak S, Tai ES, Tajuddin SM, Tan NYQ, Taylor KD, Teren A, Tham YC, Thiery J, Thio CHL, Thomsen H, Thorleifsson G, Toniolo D, Tönjes A, Tremblay J, Tzoulaki I, Uitterlinden AG, Vaccargiu S, van Dam RM, van der Harst P, van Duijn CM, Velez Edward DR, Verweij N, Vogelezang S, Völker U, Vollenweider P, Waeber G, Waldenberger M, Wallentin L, Wang YX, Wang C, Waterworth DM, Bin Wei W, White H, Whitfield JB, Wild SH, Wilson JF, Wojczynski MK, Wong C, Wong TY, Xu L, Yang Q, Yasuda M, Yerges-Armstrong LM, Zhang W, Zonderman AB, Rotter JI, Bochud M, Psaty BM, Vitart V, Wilson JG, Dehghan A, Parsa A, Chasman DI, Ho K, Morris AP, Devuyst O, Akilesh S, Pendergrass SA, Sim X, Böger CA, Okada Y, Edwards TL, Snieder H, Stefansson K, Hung AM, Heid IM, Scholz M, Teumer A, Köttgen A, Pattaro C; Lifelines Cohort Study; V. A. Million Veteran Program: A catalog of genetic loci associated with kidney function from analyses of a million individuals. Nat Genet 51: 957–972, 2019
63. Liu X, Foster MC, Tighiouart H, Anderson AH, Beck GJ, Contreras G, Coresh J, Eckfeldt JH, Feldman HI, Greene T, Hamm LL, He J, Horwitz E, Lewis J, Ricardo AC, Shou H, Townsend RR, Weir MR, Inker LA, Levey AS; CRIC (Chronic Renal Insufficiency Cohort) Study Investigators: Non-GFR determinants of low-molecular-weight serum protein filtration markers in CKD. Am J Kidney Dis 68: 892–900, 2016
64. Foster MC, Levey AS, Inker LA, Shafi T, Fan L, Gudnason V, Katz R, Mitchell GF, Okparavero A, Palsson R, Post WS, Shlipak MG: Non-GFR determinants of low-molecular-weight serum protein filtration markers in the elderly: AGES-kidney and MESA-kidney. Am J Kidney Dis 70: 406–414, 2017
65. Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, Froissart M, Kusek JW, Zhang YL, Coresh J, Levey AS: Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 75: 652–660, 2009
66. Filler G, Bökenkamp A, Hofmann W, Le Bricon T, Martínez-Brú C, Grubb A: Cystatin C as a marker of GFR--history, indications, and future research. Clin Biochem 38: 1–8, 2005
67. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, de Jong PE: Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65: 1416–1421, 2004
68. White CA, Ghazan-Shahi S, Adams MA: b-Trace protein: A marker of GFR and other biological pathways. Am J Kidney Dis 65: 131–146, 2015
69. Coresh J, Inker LA, Sang Y, Chen J, Shafi T, Post WS, Shlipak MG, Ford L, Goodman K, Perichon R, Greene T, Levey AS: Metabolomic profiling to improve glomerular filtration rate estimation: A proof-of-concept study. Nephrol Dial Transplant 34: 825–833, 2019
70. Freed TA, Coresh J, Inker LA, Toal DR, Perichon R, Chen J, Goodman KD, Zhang Q, Conner JK, Hauser DM, Vroom KET, Oyaski ML, Wulff JE, Eiríksdóttir G, Gudnason V, Torres VE, Ford LA, Levey AS: Validation of a metabolite panel for a more accurate estimation of glomerular filtration rate using quantitative LC-MS/ MS. Clin Chem 65: 406–418, 2019
71. Inker LA, Levey AS, Coresh J: Estimated glomerular filtration rate from a panel of filtration markers-hope for increased accuracy beyond measured glomerular filtration rate? Adv Chronic Kidney Dis 25: 67–75, 2018
72. Levey AS, Tighiouart H, Titan SM, Inker LA: Estimating GFR with and without race. JAMA Intern Med 180: 2020, In press
73. Purnell TS, Luo X, Cooper LA, Massie AB, Kucirka LM, Henderson ML, Gordon EJ, Crews DC, Boulware LE, Segev DL: Association of race and ethnicity with live donor kidney transplantation in the United States from 1995 to 2014. JAMA 319: 49–61, 2018
74. Derose SF, Rutkowski MP, Crooks PW, Shi JM, Wang JQ, Kalantar-Zadeh K, Kovesdy CP, Levin NW, Jacobsen SJ: Racial differences in estimated GFR decline, ESRD, and mortality in an integrated health system. Am J Kidney Dis 62: 236–244, 2013
75. Grams ME, Rebholz CM, Chen Y, Rawlings AM, Estrella MM, Selvin E, Appel LJ, Tin A, Coresh J: Race, APOL1 risk, and eGFR decline in the general population. J Am Soc Nephrol 27: 2842–2850, 2016